(Q36105459)

12 August 2017

1 reference

title

Polymorphisms of oxidation at carbon centers of drugs and their clinical significance (English)

1 reference

12 August 2017

Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance (English)

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

14 May 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A158499

14 May 2022

1

J. R. Idle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A158499

14 May 2022

author name string

R. L. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A158499

14 May 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

12 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/03602537908993896

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

14 May 2022

published in

Drug Metabolism Reviews

1 reference

12 August 2017

9

1 reference

12 August 2017

301-317

1 reference

12 August 2017

2

1 reference

Biochemical and genetic factors regulating dilantin metabolism in man.

12 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Metabolism of debrisoquine sulphate in rat, dog and man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Treatment of Data from Drug Urinary Excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Clinical consequences of polymorphic acetylation of basic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Disease and Acetylation Polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537908993896

Acetophenetidin-induced methemoglobinemia

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure

14 May 2022

3

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

Studies on debrisoquine sulphate

14 May 2022

4

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

The Metabolism and Excretion of Guanoxan in Man

14 May 2022

9

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

Hypotensive response to debrisoquine and hydroxylation phenotype

14 May 2022

15

1 reference

https://api.crossref.org/works/10.3109/03602537908993896

14 May 2022

Identifiers

1 reference

12 August 2017

1 reference